Q2 2014 Supplementary Slides July 24, 2014 1
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw”) may contain forward-looking statements about Loblaw’s objectives, plans, goals, aspirations, strategies, prospects and opportunities. It may also contain statements about the acquisition by Loblaw of Shoppers Drug Mart, including, but not limited to, statements relating to the strategic benefits expected to result from the transaction. Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions. Forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. Loblaw can give no assurance that such estimates, beliefs and assumptions will prove to be correct as they are inherently subject to significant business, economic, competitive and other risks and uncertainties, and as such, are subject to change. Information on these risks and uncertainties are included in reports filed by Loblaw and Shoppers Drug Mart with applicable securities regulatory authorities and may be accessed through the SEDAR website (www.sedar.com). Other risks and uncertainties not presently known to Loblaw or that Loblaw presently believes are not material could also cause actual results or events to differ materially from those expressed in its forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements. Loblaw disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. This presentation uses certain non-GAAP measures, such as Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA and Adjusted EPS which Loblaw believes provide useful information to both management and investors in measuring financial performance. These measurers do not have a standard meaning prescribed by GAAP and therefore they may not be comparable to similarly titled measurers presented by other publicly traded companies, and should not be construed as an alternative to other financial measures determined in accordance with GAAP. 2
Key Financial Metrics – Loblaw – Q2 2014 Consolidated Revenue +37.1% (+2.4% ex. Shoppers Drug Mart) Adjusted Operating Income +65.1% (-1.8% ex. Shoppers Drug Mart) Adjusted EBITDA +54.2% (flat ex. Shoppers Drug Mart) Adjusted EPS +17.2% Retail Revenue (ex SDM) +1.6% Retail Adjusted Gross Margin (ex SDM) 22.1% (-20bps) Retail Adjusted EBITDA Margin 6.2% (-40bps) (ex SDM) +45bps in labour and supply chain partially offset by Net Efficiencies Achieved (ex SDM) ~25bps franchise investments ~20bps incremental collective labour agreements Other notable costs (ex SDM) ~15bps derivatives gain in Q2 2013 Free Cash Flow $801M QTD, $381M YTD Capex ($) $338M YTD 3
Key Operational Metrics – Q2 2014 — Loblaw 0.8% – vs Q2/13 Loblaw Square Footage Growth 3.1% – vs Q2/13 Industry STM* Square Footage Growth Basket Size Increase in fresh penetration drove higher baskets Traffic Slight decline driven by competitive square footage growth Tonnage In line with the overall market Internal Inflation In line with CPI PC Plus Over 6.2 million total members 1.8% (excl. Shoppers Drug Mart; 1.7% adjusted for Same Store Sales Easter timing) Net Promoter Score – LCL National Over 70% of our banners are in the performance zone *Supermarket Type Merchandise 4
Key Financial Metrics – Q2 2014 - Shoppers Drug Mart Revenue +2.8% Adjusted Operating Income +1.9% (-2.8% excluding synergies) Adjusted Operating Margin 8.4% (-10bps) Adjusted EBITDA +1.1% Adjusted EBITDA Margin 10.8% (-20bps) Adjusted Gross Profit -30bps Adjusted SG&A -20bps 5
Key Operational Metrics – Q2 2014 Shoppers Drug Mart +1.8% Retail Square Footage Growth +2.5% Pharmacy Sales Pharmacy SSS +2.5% +4.1% (+3.8% on same store sales basis) # Rx Dispensed (Rx Count) -1.7% Average Rx Value 62.8% (vs 61.3% Q2 2013) Generic Penetration +3.0% Front of Store Sales +2.4% Front of Store SSS Loyalty (Optimum) Over 10 million active members 6
Adjusted Debt by Segment Q2 2014 Retail PCF REIT Con. & Elim. Bank Indebtedness $ 335 $ 335 $ - $ - $ - Short term debt 605 - 605 - - Long term debt due within one year 74 41 33 - - Long term debt 11,797 7,961 1,245 6,670 (4,079) (a) Trust Unit Liability 715 - - - 715 Capital securities 224 224 - - - Certain other liabilities 34 34 - - - $ 13,784 $ 8,595 $ 1,883 $ 6,670 ($ 3,364) Less: PCF Debt Independent Securitization Trusts in S-T debt 605 - 605 - - Independent Securitization Trusts in L-T debt 750 - 750 - - Guaranteed Investment Certificates 528 - 528 - - Independent Funding Trusts 476 476 - - - Trust Unit Liability 715 - - - 715 Total Adjusted Debt $ 10,710 $ 8,119 - $ 6,670 ($ 4,079) (a) REIT debt includes Class C LP units, and Class B exchangeable units held by Loblaw retail, eliminated in the consolidation and eliminations segment. 7
Adjusted Debt Q1 2014 Reported Adjusted Debt $6,434 Capital Securities -added to the definition of Adjusted Debt 224 $6,658 $3.5B term loan to partially fund the cash portion of the purchase price for Shoppers Drug Mart 3,500 Shoppers Drug Mart MTN's assumed on acquisition 500 Bank Indebtedness 296 $4,402 Finance Leases 145 Transaction Costs (41) Other 2 Adjusted Debt at Acquisition $11,060 $1.5B Choice Properties REIT Monetization 1,500 $1.6B repayment of term loan (1,600) ($350) 4.85% MTN matured and repaid (350) Other 100 Q2 2014 Reported Adjusted Debt $10,710 8
Recommend
More recommend
